SCHEDULE 13G: Whitefort Capital Management Discloses 6% Stake in OmniAb, Inc.
Beneficial Ownership Report
Whitefort Capital Management, LP, along with its co-managing partners David Salanic and Joseph Kaplan, has reported a 6% beneficial ownership stake in OmniAb, Inc.
Summary
- Whitefort Capital Management, LP, a Delaware limited partnership, along with its Co-Managing Partners, David Salanic (French citizen) and Joseph Kaplan (United States citizen), collectively referred to as the "Reporting Persons," have filed a Schedule 13G.
- The filing indicates beneficial ownership of 7,313,358 shares of Common Stock, $0.0001 par value per share, in OmniAb, Inc.
- This ownership represents 6.0% of OmniAb, Inc.'s outstanding shares, based on 122,335,336 shares outstanding as of May 1, 2025, as reported in the Issuer's Form 10-Q filed on May 8, 2025.
- The beneficial ownership was reported as of the close of business on June 2, 2025.
- The Reporting Persons explicitly state that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of OmniAb, Inc., nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently indicate a strong positive or negative sentiment regarding the issuer's operational performance or future prospects. The acquisition of a significant stake by an institutional investor can be seen as a neutral to slightly positive signal of confidence.
Positives
- The disclosure of a 6% stake by an investment management firm like Whitefort Capital Management can be interpreted as a vote of confidence in OmniAb, Inc. by a significant institutional investor.
Risks
- The filing explicitly states that the shares were not acquired for the purpose of changing or influencing the control of the issuer, mitigating immediate activist investor risk from this specific filing.
Future Outlook
NA
Industry Context
This filing indicates a significant institutional investment in OmniAb, Inc., a common occurrence in the public markets where investment firms take positions in companies they believe are undervalued or have growth potential. It does not provide specific insights into broader industry trends beyond the general activity of institutional investment.
Stakeholder Impact
- Shareholders: The disclosure of a new significant institutional investor may influence investor perception and potentially the stock price, signaling increased institutional interest in OmniAb, Inc.
Key Dates
| Date | Description |
|---|---|
| 2025-05-01 | Date as of which OmniAb, Inc.'s outstanding shares (122,335,336) were reported in its Form 10-Q. |
| 2025-05-08 | Date OmniAb, Inc. filed its Form 10-Q with the SEC. |
| 2025-05-30 | Date of the event which required the filing of this statement. |
| 2025-06-02 | Date as of which the beneficial ownership of 7,313,358 shares was reported. |
| 2025-06-06 | Date the Schedule 13G statement was signed and filed. |
Keywords
OmniAb Inc., Whitefort Capital Management, David Salanic, Joseph Kaplan, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.